IL17A and rheumatoid arthritis: Our results, based on in vitro and in vivo experiments and data from SS patients, suggest that decreased RA levels exacerbate SS by retaining IL-17-producing immune cells in the peripheral blood, salivary glands, and spleen instead of their migration to the gut.